[Dapagliflozin/metformin (type 2 diabetes mellitus) - Addendum to Commission A19-52]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003623
German
Original Title: Dapagliflozin/Metformin (Diabetes mellitus Typ 2) - Addendum zum Auftrag A19-52
Details
Project Status: Completed
Year Published: 2019
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Diabetes Mellitus, Type 2
  • Metformin
  • Drug Therapy, Combination
  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents
Keywords
  • Dapagliflozin
  • Metformin
  • Diabetes Mellitus - Typ 2
  • Nutzenbewertung
  • NCT01730534
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.